SANUWAVE Health, Inc.
SNWV
$33.98
$0.020.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.34% | 41.92% | 61.46% | 47.64% | 88.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.34% | 41.92% | 61.46% | 47.64% | 88.98% |
| Cost of Revenue | 10.16% | 14.78% | 23.61% | 5.84% | 62.39% |
| Gross Profit | 26.29% | 51.87% | 75.73% | 66.31% | 99.58% |
| SG&A Expenses | 45.17% | 98.85% | 22.23% | 48.50% | 27.61% |
| Depreciation & Amortization | 7.77% | -3.33% | 5.49% | 16.93% | 10.16% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.79% | 60.29% | 22.24% | 31.05% | 35.07% |
| Operating Income | -24.88% | -5.77% | 193.90% | 142.73% | 467.80% |
| Income Before Tax | 149.98% | -83.92% | -25.35% | -169.75% | 12.84% |
| Income Tax Expenses | -- | -- | -- | 575.00% | -- |
| Earnings from Continuing Operations | 149.98% | -83.92% | -25.35% | -169.91% | 12.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 149.98% | -83.92% | -25.35% | -169.91% | 12.84% |
| EBIT | -24.88% | -5.77% | 193.90% | 142.73% | 467.80% |
| EBITDA | -19.58% | -8.58% | 230.74% | 127.74% | 900.75% |
| EPS Basic | 118.58% | -94.08% | 54.55% | -124.92% | 34.85% |
| Normalized Basic EPS | 119.79% | -68.95% | 53.47% | -127.05% | 34.85% |
| EPS Diluted | 107.13% | -99.60% | 54.55% | -124.92% | 34.80% |
| Normalized Diluted EPS | 118.55% | -65.97% | 53.47% | -127.05% | 34.85% |
| Average Basic Shares Outstanding | 169.07% | 171.58% | 175.79% | 180.57% | 33.79% |
| Average Diluted Shares Outstanding | 186.95% | 147.81% | 175.79% | 180.57% | 33.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |